Funds holding Contineum Therapeutics Inc
ISIN US21217B1008 · United States
- Fund holders
- 102
- Of which ETFs
- 16 86 other funds
- Value held
- 89.9M $
- Share of capital
- 24.8 % of 23.1M shares on Oct 27, 2025
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SMALL-CAP PROFUND ProFunds | 23 | 356.3 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 8 | 131.1 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.84 % | as of Jul 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.37 % | as of Jun 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.30 % | as of Jun 30, 2026 ↗ |
| Fidelity Small Cap Stock Fund Fidelity Concord Street Trust | 0.20 % | as of Jul 31, 2026 ↗ |
| Fidelity Small Cap Stock K6 Fund Fidelity Concord Street Trust | 0.20 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.16 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 0.14 % | as of Jul 31, 2026 ↗ |
| Allspring Disciplined Small Cap Fund ALLSPRING FUNDS TRUST | 0.12 % | as of Jun 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 0.11 % | as of Jun 30, 2026 ↗ |
| Small Cap Value Fund Northern Funds | 0.11 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 102 | +58 | 5,739,058 | +65.2 % |
| 2026Q2 | 44 | +13 | 3,474,483 | +9.1 % |
| 2026Q1 | 31 | +7 | 3,185,349 | +29.9 % |
| 2025Q4 | 24 | -6 | 2,451,847 | +3.6 % |
| 2025Q3 | 30 | -53 | 2,367,210 | -18.7 % |
| 2025Q2 | 83 | -3 | 2,912,800 | +11.7 % |
| 2025Q1 | 86 | +3 | 2,607,339 | +22.2 % |
| 2024Q4 | 83 | +51 | 2,133,068 | +75.8 % |
| 2024Q3 | 32 | +30 | 1,213,217 | +151.8 % |
| 2024Q2 | 2 | 481,767 |
Institutional managers
86 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,841,334 | 37.1M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,734,836 | 35.6M $ | as of Mar 31, 2026 |
| JOHNSON & JOHNSON | 1,979,173 | 25.8M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,839,227 | 24M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 1,685,635 | 22M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,535,449 | 20.1M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 1,420,838 | 18.6M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 1,296,012 | 16.9M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,255,592 | 16.4M $ | as of Mar 31, 2026 |
| FMR LLC | 814,871 | 10.6M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 807,874 | 10.6M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 800,198 | 10.5M $ | as of Mar 31, 2026 |
| Longaeva Partners L.P. | 732,088 | 9.6M $ | as of Mar 31, 2026 |
| SECTORAL ASSET MANAGEMENT INC | 727,587 | 9.5M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 669,337 | 8.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 669,123 | 8.7M $ | as of Mar 31, 2026 |
| RED TREE MANAGEMENT, LLC | 638,158 | 8.3M $ | as of Mar 31, 2026 |
| Versant Venture Management, LLC | 542,628 | 7.1M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 513,053 | 6.7M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 494,000 | 6.5M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 371,636 | 4.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 350,200 | 4.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 307,108 | 4M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 301,729 | 3.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 282,038 | 3.7M $ | as of Mar 31, 2026 |
Declared shareholders of Contineum Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. and 4 others | 7.14 % | 2,335,550 | as of Jun 30, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 6.30 % | 2,049,493 | as of Jun 30, 2026 · SCHEDULE 13G |
| Millennium Management LLC and 2 others | 2.80 % | 931,709 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Contineum Therapeutics Inc". https://titelia.com/en/stocks/contineum-therapeutics-inc-US21217B1008